Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2012
08/16/2012US20120207799 Oral delivery vehicle and material
08/16/2012US20120207798 Solid Oral Dosage Form Attached to a Handle
08/16/2012US20120207797 Dosage forms for tamper prone therapeutic agents
08/16/2012US20120207796 Polymeric drug delivery compositions and methods for treating ophthalmic diseases
08/16/2012US20120207795 Cationic polymer coated mesoporous silica nanoparticles and uses thereof
08/16/2012US20120207794 Water-soluble drug carrier and process for producing the same
08/16/2012US20120207793 Methods and Compositions for Controlled and Sustained Production and Delivery of Peroxides and/or Oxygen for Biological and Industrial Applications
08/16/2012US20120207792 Injectable filler for podiatric and orthopedic uses
08/16/2012US20120207791 Immobilized biologically active entities having a high degree of biological activity
08/16/2012US20120207732 Compositions and methods for promoting neuronal outgrowth
08/16/2012US20120207685 Non-ozone depleting medicinal formulations with low greenhouse effect
08/16/2012US20120207682 Methods of treating macular edema using antiedema therapeutics
08/16/2012US20120205274 Allograft bone composition having a gelatin binder
08/16/2012US20120204871 Stable, non-corrosive formulations for pressurized metered dose inhalers
08/16/2012DE102009056883B4 Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben Vaccine adjuvants and to improved methods for the preparation thereof
08/16/2012CA2827069A1 Sildenafil-free base-containing film preparation and method for producing same
08/16/2012CA2827062A1 Storage-stable formulation of paracetamol in aqueous solution
08/16/2012CA2826741A1 Novel antifungal composition
08/16/2012CA2826629A1 Artificial oil bodies
08/16/2012CA2826183A1 Novel composition for the treatment of cystic fibrosis
08/16/2012CA2825964A1 Forms of rifaximin and uses thereof
08/16/2012CA2825053A1 Effervescent gamma-hydroxybutyric acid granules
08/16/2012CA2824578A1 Citrate free pharmaceutical compositions comprising anakinra
08/16/2012CA2824333A1 Novel formulations for dermal, transdermal and mucosal use 1
08/15/2012EP2486944A1 Magnetic nanoparticles
08/15/2012EP2486942A1 Compositions comprising azelastine and methods of use thereof
08/15/2012EP2486937A1 Methods for treating a urethral stricture with a botulinum toxin
08/15/2012EP2486922A1 Composition comprising benzoic acid in combination with organic acid preservatives as active components and use thereof
08/15/2012EP2486919A1 A chinese medicine composition and preparation method and use thereof
08/15/2012EP2486918A2 Pharmaceutical composition with both immediate and extended release characteristics
08/15/2012EP2486917A1 Coating film, and granules and tablets each utilizing same
08/15/2012EP2486916A1 Human growth hormone formulations
08/15/2012EP2486915A1 Topical pharmaceutical compositions comprising flurbiprofen and methylsulfonylmethane
08/15/2012EP2486914A2 Stable, non-corrosive formulations for pressurized metered dose inhalers
08/15/2012EP2486913A1 Rapidly disintegrating oral film formulation for Olanzapin
08/15/2012EP2486128A1 Use of pedf in an encapsulated cell-based delivery system
08/15/2012EP2485754A1 Methods and compositions for skin regeneration
08/15/2012EP2485746A2 Cytoprotective or therapeutic plant composition
08/15/2012EP2485744A2 Compositions and methods comprising pediococcus for reducing at least one symptom associated with autism spectrum disease in a person diagnosed with an autism spectrum disease
08/15/2012EP2485742A1 Antibiotic formulations providing reduced gastrointentestinal side effects
08/15/2012EP2485730A1 Topical formulation comprising etoricoxib and a zwitterionic surfactant
08/15/2012EP2485720A1 Low ether composition and delivery apparatus
08/15/2012EP2485719A1 Transdermal therapeutic system
08/15/2012EP2485718A1 Use of a compound based on eremophilanolides
08/15/2012EP2485717A1 Delivery system for sustained release of a calcium -channel blocking agent
08/15/2012EP2485716A2 Pharmaceutical composition comprising poorly soluble active ingredient and hyperbranched polymer
08/15/2012EP2485715A1 Pharmaceutical compositions comprising rivaroxaban
08/15/2012EP2485714A1 Novel pharmaceutical composition comprising a macrolide immunosuppressant drug
08/15/2012EP2485713A1 Liquid precursor compositions and uses thereof for a ph-dependant sustained release treatment of oral disorders
08/15/2012EP2485712A1 Subcutaneous paliperidone composition
08/15/2012EP2485711A1 Formulation of drugs and vaccines in the form of percutaneous injectable needles
08/15/2012EP2485710A1 Carrageenan-containing aqueous antimicrobial compositions
08/15/2012EP2485606A1 Amino acid composition with improved dispersibility
08/15/2012EP2299977B1 Liposomes for drug delivery and methods for preparation thereof
08/15/2012EP2249866B1 Use of an acetylsalicylic acid salt for the treatment of viral infections
08/15/2012EP2229154B1 Pharmaceutical containing a hormone combination having a contraceptive effect and an insulin sensitizer
08/15/2012EP2219607B1 Liquid LH formulations
08/15/2012EP2201053B1 Graft copolymers as drug delivery systems
08/15/2012EP2148658B1 Improved vitamin d content uniformity in pharmaceutical dosage forms
08/15/2012EP1978944B1 Soft-gelatin capsule formulation
08/15/2012EP1965808B1 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, processes for the preparation thereof, and uses thereof
08/15/2012EP1963558B1 Method for preparing a textile material
08/15/2012EP1940241B1 Stable, durable granules with active agents
08/15/2012EP1868569B8 Liquid aqueous dosage forms for sub-lingual or nasal applications of active agents with amino groups
08/15/2012EP1855653B1 Composition for oral application with controlled release of active substances
08/15/2012EP1727543B1 Use of 14,15-dihydro-20,21-dinoreburnamenin-14-ol for the treatment and/or prevention of serious depression
08/15/2012EP1638395B1 Physical mode of action pesticide
08/15/2012EP1420716B1 An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues
08/15/2012EP1383735B1 Methods of synthesizing acylanilides including bicalutamide and derivatives thereof
08/15/2012EP1379242B1 Method for treatment of cancer and compositions for use therein
08/15/2012CN202376488U Tablet capable of being divided into three equal parts
08/15/2012CN202376487U Drug tablet
08/15/2012CN1882693B Polyethyleneglycol-modified lipid compounds and uses thereof
08/15/2012CN1646102B Pharmaceutical preparation containing oxycodone and naloxone
08/15/2012CN102639626A Water-soluble polysaccharide ethers and the use thereof
08/15/2012CN102639611A Method for preparing a recyclable polyamide powder
08/15/2012CN102639322A Conformable barrier sheet, methods, and device
08/15/2012CN102639159A Ion substituted calcium phosphate particles
08/15/2012CN102639136A Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
08/15/2012CN102639131A Sublingual dexmedetomidine compositions and methods of use thereof
08/15/2012CN102639124A Transdermal therapeutic system for the administration of peptides
08/15/2012CN102639123A Pharmaceutical solid dosage form
08/15/2012CN102639122A Partial dip coating of dosage forms for modified release
08/15/2012CN102639121A Orally transformable tablets
08/15/2012CN102639120A Manufacture of lozenge product with radiofrequency
08/15/2012CN102639119A Manufacture of tablet having immediate release region and sustained release region
08/15/2012CN102639118A Oxidation-stabilized tamper-resistant dosage form
08/15/2012CN102639117A New compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine
08/15/2012CN102639116A New oral formulations for tetrapyrrole derivatives
08/15/2012CN102639115A Lipid formulated compositions and methods for inhibiting expression of EG5 and VEGF genes
08/15/2012CN102639114A Liposomes with improved storage stability
08/15/2012CN102639113A Formulations for the treatment of deep tissue pain
08/15/2012CN102639112A Ophthalmic emulsion
08/15/2012CN102639111A Ophthalmic preparations based on BDNF (brain-derived neurotrophic factor) and their use
08/15/2012CN102639110A Manufacture of tablet in a die utilizing powder blend containing water-containing material
08/15/2012CN102639101A Method for manufacturing a silica powder coated with an antibacterial agent, and topical dermatological composition including same
08/15/2012CN102639098A Foamable oil-water emulsion
08/15/2012CN102639097A Reverse thermo-sensitivity reversible aquogel composite
08/15/2012CN102636626A Compound medicine screening method, obtained medicines and application thereof
08/15/2012CN102634531A Medicine T-VISA-PEA15 capable of effectively and specifically killing breast cancer cells
1 ... 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 ... 2991